267 related articles for article (PubMed ID: 21572391)
21. TRIM37 Augments AP-2γ Transcriptional Activity and Cellular Localization via K63-linked Ubiquitination to Drive Breast Cancer Progression.
Cui G; Gao Z; Chang S; Narwade N; Chen Y; Poudel B; Lei KMK; Zhang W; Li G; Poon TCW; Cheung E
Int J Biol Sci; 2022; 18(11):4316-4328. PubMed ID: 35864973
[TBL] [Abstract][Full Text] [Related]
22. Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells.
Lin CY; Chao A; Wang TH; Lee LY; Yang LY; Tsai CL; Wang HS; Lai CH
Oncotarget; 2016 Sep; 7(37):60038-60052. PubMed ID: 27527851
[TBL] [Abstract][Full Text] [Related]
23. Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha.
Frietze S; O'Geen H; Littlepage LE; Simion C; Sweeney CA; Farnham PJ; Krig SR
BMC Genomics; 2014 Jun; 15(1):520. PubMed ID: 24962896
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide identification of estrogen receptor alpha-binding sites in mouse liver.
Gao H; Fält S; Sandelin A; Gustafsson JA; Dahlman-Wright K
Mol Endocrinol; 2008 Jan; 22(1):10-22. PubMed ID: 17901129
[TBL] [Abstract][Full Text] [Related]
25. E6-AP facilitates efficient transcription at estrogen responsive promoters through recruitment of chromatin modifiers.
Catoe HW; Nawaz Z
Steroids; 2011 Aug; 76(9):897-902. PubMed ID: 21530567
[TBL] [Abstract][Full Text] [Related]
26. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
[TBL] [Abstract][Full Text] [Related]
28. Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.
Nolens G; Pignon JC; Koopmansch B; Elmoualij B; Zorzi W; De Pauw E; Winkler R
Breast Cancer Res; 2009; 11(6):R83. PubMed ID: 19906305
[TBL] [Abstract][Full Text] [Related]
29. PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer.
Magnani L; Ballantyne EB; Zhang X; Lupien M
PLoS Genet; 2011 Nov; 7(11):e1002368. PubMed ID: 22125492
[TBL] [Abstract][Full Text] [Related]
30. Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs.
Madak-Erdogan Z; Lupien M; Stossi F; Brown M; Katzenellenbogen BS
Mol Cell Biol; 2011 Jan; 31(1):226-36. PubMed ID: 20956553
[TBL] [Abstract][Full Text] [Related]
31. Fucosyltransferase 8 regulation and breast cancer suppression by transcription factor activator protein 2γ.
Ma M; Guo D; Tan Z; Du J; Guan F; Li X
Cancer Sci; 2021 Aug; 112(8):3190-3204. PubMed ID: 34036684
[TBL] [Abstract][Full Text] [Related]
32. An oestrogen-receptor-alpha-bound human chromatin interactome.
Fullwood MJ; Liu MH; Pan YF; Liu J; Xu H; Mohamed YB; Orlov YL; Velkov S; Ho A; Mei PH; Chew EG; Huang PY; Welboren WJ; Han Y; Ooi HS; Ariyaratne PN; Vega VB; Luo Y; Tan PY; Choy PY; Wansa KD; Zhao B; Lim KS; Leow SC; Yow JS; Joseph R; Li H; Desai KV; Thomsen JS; Lee YK; Karuturi RK; Herve T; Bourque G; Stunnenberg HG; Ruan X; Cacheux-Rataboul V; Sung WK; Liu ET; Wei CL; Cheung E; Ruan Y
Nature; 2009 Nov; 462(7269):58-64. PubMed ID: 19890323
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells.
Caizzi L; Ferrero G; Cutrupi S; Cordero F; Ballaré C; Miano V; Reineri S; Ricci L; Friard O; Testori A; Corà D; Caselle M; Di Croce L; De Bortoli M
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4892-7. PubMed ID: 24639548
[TBL] [Abstract][Full Text] [Related]
34. Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.
Chang EC; Charn TH; Park SH; Helferich WG; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
Mol Endocrinol; 2008 May; 22(5):1032-43. PubMed ID: 18258689
[TBL] [Abstract][Full Text] [Related]
35. AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells.
Li H; Goswami PC; Domann FE
Neoplasia; 2006 Jul; 8(7):568-77. PubMed ID: 16867219
[TBL] [Abstract][Full Text] [Related]
36. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor.
Wang C; Mayer JA; Mazumdar A; Fertuck K; Kim H; Brown M; Brown PH
Mol Endocrinol; 2011 Sep; 25(9):1527-38. PubMed ID: 21835891
[TBL] [Abstract][Full Text] [Related]
37. GATA4 regulates estrogen receptor-alpha-mediated osteoblast transcription.
Miranda-Carboni GA; Guemes M; Bailey S; Anaya E; Corselli M; Peault B; Krum SA
Mol Endocrinol; 2011 Jul; 25(7):1126-36. PubMed ID: 21566084
[TBL] [Abstract][Full Text] [Related]
38. Identification of a Wells-Dawson polyoxometalate-based AP-2γ inhibitor with pro-apoptotic activity.
Hu J; Tan SK; Lim MGL; Chang SH; Cui G; Liu S; Narasimhan K; New SY; Wang X; Chen C; Chakravarty H; Kolatkar PR; Tam KY; Lu Q; Su X; Jauch R; Cheung E
Biochem J; 2018 Jun; 475(11):1965-1977. PubMed ID: 29760237
[TBL] [Abstract][Full Text] [Related]
39. Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells.
Lai CF; Flach KD; Alexi X; Fox SP; Ottaviani S; Thiruchelvam PT; Kyle FJ; Thomas RS; Launchbury R; Hua H; Callaghan HB; Carroll JS; Charles Coombes R; Zwart W; Buluwela L; Ali S
Nucleic Acids Res; 2013 Dec; 41(22):10228-40. PubMed ID: 24049078
[TBL] [Abstract][Full Text] [Related]
40. Sp1 and Sp3 Are important regulators of AP-2gamma gene transcription.
Li M; Kellems RE
Biol Reprod; 2003 Oct; 69(4):1220-30. PubMed ID: 12801994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]